Is (poly-) substance use associated with impaired inhibitory control? A mega-analysis controlling for confounders.

Autor: Liu Y; Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands; Addiction, Development, and Psychopathology (ADAPT) Lab, Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: liu.yang.ocean1@gmail.com., van den Wildenberg WPM; Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands; Amsterdam Brain and Cognition Center, University of Amsterdam, Amsterdam, the Netherlands., de Graaf Y; Faculty of Science (FNWI), University of Amsterdam, Amsterdam, the Netherlands., Ames SL; School of Community and Global Health, Claremont Graduate University, Claremont, CA, USA., Baldacchino A; Division of Population and Behavioural Sciences, St Andrews University Medical School, University of St Andrews, St Andrews, Scotland, UK., Bø R; Clinical Neuroscience Research Group, Department of Psychology, University of Oslo, Oslo, Norway., Cadaveira F; Department of Clinical Psychology and Psychobiology, University of Santiago de Compostela, Galicia, Spain., Campanella S; Laboratoire de Psychologie Médicale et d'Addictologie, ULB Neuroscience Institute (UNI), CHU Brugmann-Université Libre de Bruxelles (U.L.B.), Brussels, Belgium., Christiansen P; Department of Psychological Sciences, University of Liverpool, Liverpool, UK., Claus ED; The Mind Research Network and Lovelace Biomedical and Environmental Research Institute, Albuquerque, NM, USA., Colzato LS; Leiden University, Cognitive Psychology Unit & Leiden Institute for Brain and Cognition, Leiden, the Netherlands., Filbey FM; Center for BrainHealth, School of Behavioral and Brain Sciences, The University of Texas at Dallas, TX, USA., Foxe JJ; University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, USA., Garavan H; Department of Psychiatry, University of Vermont, Burlington, USA., Hendershot CS; Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute and Institute for Mental Health Policy Research, Toronto, Canada., Hester R; School of Psychological Sciences, University of Melbourne, Melbourne, Australia., Jester JM; Department of Psychiatry, University of Michigan, MI, USA., Karoly HC; Institute of Cognitive Science, University of Colorado Boulder, CO, USA., Kräplin A; Work Group Addictive Behaviours, Risk Analyses and Risk Management, Faculty of Psychologie, Technische Universität Dresden, Germany., Kreusch F; Department of Psychology, University of Liège, Belgium., Landrø NI; Clinical Neuroscience Research Group, Department of Psychology, University of Oslo, Oslo, Norway., Littel M; Department of Psychology, Erasmus University Rotterdam, Rotterdam, the Netherlands., Loeber S; Department of Clinical Psychology and Psychotherapy, University of Bamberg, Bamberg, Germany., London ED; Department of Psychiatry and Biobehavioral Sciences at the University of California, Los Angeles, USA., López-Caneda E; Psychological Neuroscience Lab, Research Center in Psychology (CIPsi), School of Psychology, University of Minho, Braga, Portugal., Lubman DI; Turning Point, Eastern Health and Eastern Health Clinical School, Monash University, Melbourne, Australia., Luijten M; Behavioural Science Institute, Radboud University, Nijmegen, the Netherlands., Marczinski CA; Northern Kentucky University, Highland Heights, USA., Metrik J; Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, USA., Montgomery C; School of Natural Sciences and Psychology, Liverpool John Moores University, Liverpool, UK., Papachristou H; Maastricht University, Faculty of Psychology and Neuroscience, the Netherlands., Mi Park S; Department of Psychiatry, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea; Department of Clinical Medical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea., Paz AL; Department of Psychology, Charles Schmidt College of Science, Florida Atlantic University, USA., Petit G; Department of Psychological Sciences, University of Liverpool, Liverpool, UK., Prisciandaro JJ; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA., Quednow BB; Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland., Ray LA; University of California Los Angeles, Department of Psychology, Los Angeles, CA, USA., Roberts CA; Department of Psychological Sciences, University of Liverpool, Liverpool, UK., Roberts GMP; School of Psychiatry, University of New South Wales, Sydney, Australia., de Ruiter MB; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Rupp CI; Department of Psychiatry, Psychotherapy and Psychosomatic, Medical University Innsbruck, Austria., Steele VR; The Mind Research Network and Lovelace Biomedical and Environmental Research Institute, Albuquerque, NM, USA., Sun D; Duke Brain Imaging and Analysis Center, Duke University School of Medicine, Durham, NC, USA; Mid-Atlantic Mental Illness Research, Education and Clinical Center (MIRECC), Durham, NC, USA., Takagi M; Child Neuropsychology Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia., Tapert SF; Department of Psychiatry, University of California, San Diego, USA., van Holst RJ; Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam Institute for Addiction Research, Amsterdam, the Netherlands., Verdejo-Garcia A; Turner Institute for Brain and Mental Health, Monash University, Melbourne, Australia., Vonmoos M; Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland., Wojnar M; Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland., Yao Y; State Key Laboratory of Cognitive Neuroscience and Learning and IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China., Yücel M; School of Psychological Sciences, Turner Institute for Brain and Mental Health, Monash Biomedical Imaging Facility, Monash University, Melbourne, Victoria, Australia., Zack M; Molecular Brain Science Research Section Centre for Addiction and Mental Health, Toronto, Canada., Zucker RA; Department of Psychiatry, University of Michigan, MI, USA., Huizenga HM; Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands; Amsterdam Brain and Cognition Center, University of Amsterdam, Amsterdam, the Netherlands; Research Priority Area Yield, Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands., Wiers RW; Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands; Addiction, Development, and Psychopathology (ADAPT) Lab, Department of Psychology, University of Amsterdam, Amsterdam, the Netherlands.
Jazyk: angličtina
Zdroj: Neuroscience and biobehavioral reviews [Neurosci Biobehav Rev] 2019 Oct; Vol. 105, pp. 288-304. Date of Electronic Publication: 2019 Jul 15.
DOI: 10.1016/j.neubiorev.2019.07.006
Abstrakt: Many studies have reported that heavy substance use is associated with impaired response inhibition. Studies typically focused on associations with a single substance, while polysubstance use is common. Further, most studies compared heavy users with light/non-users, though substance use occurs along a continuum. The current mega-analysis accounted for these issues by aggregating individual data from 43 studies (3610 adult participants) that used the Go/No-Go (GNG) or Stop-signal task (SST) to assess inhibition among mostly "recreational" substance users (i.e., the rate of substance use disorders was low). Main and interaction effects of substance use, demographics, and task-characteristics were entered in a linear mixed model. Contrary to many studies and reviews in the field, we found that only lifetime cannabis use was associated with impaired response inhibition in the SST. An interaction effect was also observed: the relationship between tobacco use and response inhibition (in the SST) differed between cannabis users and non-users, with a negative association between tobacco use and inhibition in the cannabis non-users. In addition, participants' age, education level, and some task characteristics influenced inhibition outcomes. Overall, we found limited support for impaired inhibition among substance users when controlling for demographics and task-characteristics.
(Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: